PCS
BSX icon

Personal CFO Solutions’s Boston Scientific BSX Stock Holding History

Personal CFO Solutions’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310K Sell
4,939
-4,139
-46% -$331K 0.04% 367
2025
Q4 		$866K Buy
9,078
+403
+5% +$39.5K 0.14% 143
2025
Q3 		$847K Buy
8,675
+5,882
+211% +$609K 0.15% 138
2025
Q2 		$300K Buy
2,793
+624
+29% +$63.1K 0.06% 331
2025
Q1 		$219K Buy
+2,169
New +$218K 0.04% 406

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Personal CFO Solutions's BSX Position: Q1 2026 in Review

Personal CFO Solutions reduced its Boston Scientific (BSX) stake by 46% in Q1 2026, selling an estimated $331K and leaving 4,939 shares worth $310K. The position accounts for 0.04% of the portfolio, ranked #367.

Personal CFO Solutions first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. The position peaked at $866K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Personal CFO Solutions held 4,939 shares of Boston Scientific worth $310K as of Q1 2026.
  • Personal CFO Solutions sold 4,139 Boston Scientific shares in Q1 2026, an estimated $331K.
  • Boston Scientific made up 0.04% of Personal CFO Solutions's portfolio in Q1 2026, its #367 holding.
  • Personal CFO Solutions first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
  • Personal CFO Solutions's Boston Scientific position peaked at $866K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Personal CFO Solutions's 13F filing for Q1 2026, filed 30 Apr 2026.